Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11118186
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 11117865
Inhibitors of bromodomain-containing protein 4 (BRD4)
granted -
US 11110067
Inhibition of mammalian target of rapamycin
granted -
US 11111278
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 11103460
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
granted -
US 11104719
Recombinant clusterin and use thereof in the treatment and prevention of disease
granted -
US 11097017
Gadolinium-based contrast agents for sensitive detection of Zn2+with MRI
granted -
US 11098150
Block copolymer and micelle compositions and methods of use thereof
granted -
US 11096910
Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
granted -
US 11090286
Methods of treating and preventing breast cancer with S-equol
granted -
US 11090311
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11091516
Synthetic binder of breast cancer stem cells
granted -
US 11090344
Adenovirus and immunomodulator combination therapy
granted -
US 11084869
Antibody-mediated neutralization of Marburg virus
granted -
US 11076599
Antimicrobial coating comprising chalcogenide nano-particles capped by chitosan
granted -
US 11078256
Methods and compositions for inhibiting cancer cell growth
granted -
US 11065223
Antimicrobial compositions and uses thereof
granted -
US 11065285
Biomarkers and combination therapies using oncolytic virus and immunomodulation
granted -
US 11059879
Chimeric antigen receptor molecules and uses thereof
granted -
US 11058802
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11058688
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 11054423
Antibody-mediated neutralization of ebolaviruses
granted -
US 11045443
Glutaminase inhibitor therapy
granted -
US 11046670
Piperazinyl norbenzomorphan compounds and methods for using the same
granted